Testbed Sweden Precision Health Cancer

In 2021, Vision Zero Cancer, Genomic Medicine Sweden (GMS) and SciLifeLab joined forces with public sector authorities, regions, healthcare, academia, industry and patient associations to create an innovation hub that facilitates the introduction of more precise prevention and treatment in cancer care.

Through strengthened national and international collaboration and the use of existing national research and clinical infrastructures, the Partnership will pave the way for the next generation of medicine by 2030, centred on the individuals’ personal characteristics, and leading to increased effectiveness. The patient perspective is central to the initiative.